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American Venous Forum: The future is now!
Thomas W. Wakefield, MD, Ann Arbor, MichThe American Venous Forum is the premier organiza-
tion in the world for the study of venous disease. To
understand the position of this organization at the present
moment, I would like to take a look back at the “venous”
world at the time of the inception of the American Venous
Forum. Then, I will chronicle its present activities and end
with my thoughts about the future of our organization.
PAST
In 1989, the Joint Council of the Society for Vascular
Surgery and the North American Chapter of the Interna-
tional Society for Cardiovascular Surgery appointed a Ve-
nous Forum Committee, which founded the American
Venous Forum. The beginnings followed the very success-
ful European American Symposium on Venous Disease
held in Washington, DC, in the spring of 1987. “The
American Venous Forum was founded by academic sur-
geons to enhance education in venous problems, establish
policies of management of venous diseases and allied con-
ditions, and stimulate research into fundamental aspects of
venous pathology.” Further, “It is expected that the Amer-
ican Venous Forum will assume a role equal to the Vascular
Societies in the future.”1 I believe that you will agree with
me that in its relatively short life, this organization that I am
so proud of today has lived up to these expectations and, in
fact, far exceeded even what our founders had hoped for.
The founding members of the American Venous Fo-
rum included Robert W. Barnes, John J. Bergan, John J.
Cranley, W. Andrew Dale, Ralph DePalma, James A.
DeWeese, Lazar J. Greenfield, Robert W. Hobson, Michael
Hume, George Johnson, Jr, Robert L. Kistner, John M.
Porter, Seshadri Raju, Normal M. Rich, Charles G. Rob,
Joseph G. Sladen, D. Eugene Strandness, Jr., David S.
Sumner, J. Leonel Villavicencio, and James S. T. Yao. This
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216is certainly a star cast of venous experts, and we are indeed
fortunate that many still remain in our organization, adding
vibrancy and life to it. It is interesting to look at the first
executive committee of the American Venous Forum—
President John J. Bergan, President-elect Norman M. Rich,
Secretary J. Lionel Villavicencio, Treasurer Lazar J. Green-
field, Recorder George Johnson, Jr, and Councilors John J.
Cranley, Jr, Michael Hume, and John M. Porter. Note that
the Executive Committee included President John Bergan,
who is currently the President-elect of the American Col-
lege of Phlebology, our sister organization.
It is interesting and informative to look at the program
from the initial meeting of the American Venous Forum in
1989. First of all, note that from the outset, this organiza-
tion has embraced our international colleagues and friends.
There was wide representation of many countries in the first
International Advisory Committee, with Sweden, Italy, the
United Kingdom, Norway, Switzerland, Australia, Kuwait,
West Germany, Colombia, Brazil, Canada, Spain, and
Mexico, represented. At that first meeting, honorary guests
came from Argentina, Sweden, the United Kingdom, Ec-
uador, West Germany, Columbia, Austria, France, Switzer-
land, Greece, Italy, Kuwait, and Brazil.
Many of the topics discussed in papers in 1989 were
similar to topics discussed at the 2006 meeting. Session I
involved varicose veins; session II included the Presidential
Address of John Bergan; session III evaluated topics in
chronic venous insufficiency, and session IV focused on
venous thromboembolism, diagnosis, and treatment. Ses-
sion V included innovative treatments for complex venous
disorders including iliac vein compression syndrome, and
session VI included topics in deep venous thrombosis
(DVT) and venous surgery. Session VII focused on sclero-
therapy, and session VIII included miscellaneous topics.
Importantly, even in this first meeting, there was an audio-
visual session, and 17 industrial sponsors participated.
Some of these sponsors are still part of our meeting today,
and I want to personally thank them for their support.
Here is a list of all of the past presidents of the American
Venous Forum. Giants the likes of John Bergan, Norman
Rich, Lazar Greenfield, Michael Hume, George Johnson,
Jr., Jim DeWesse, Bob Hobson, Bob Kistner, Jimmy Yao,
Gene Strandness, Tom O’Donnell, David Sumner, Tony
Comerota, Greg Moneta, Peter Glovizcki, Frank Padberg,
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indeed lucky and feel very fortunate to now be included in
this list of leaders.
PRESENT
After a successful strategic planning retreat in the fall of
2004, I am very happy to report that the American Venous
Forum is moving forward on important patient and physi-
cian educational initiatives. I want to thank Robin Hoyle,
Eila Zay, and Angela Weatherbe from Administrare for all
of their great work over the past year for our organization
from an administrative perspective. A number of initiatives
have moved forward.
National venous screening program. The idea for
the first initiative, a National Venous Screening Program,
began at the September 2004 retreat. After discussion, an
Ad hoc Committee was formed to explore the feasibility of
this endeavor. As we began working on the project, the
American Venous Forum (AVF) also began early delibera-
tions with Bill Flinn, MD, and the American Vascular
Association (AVA). Dr Flinn and Michele Lentz, Senior
Program Administrator for the AVA, were invited to par-
ticipate in a meeting of the Ad hoc Venous Screening
Committee at the Annual AVF Meeting in San Diego on
February 9, 2005. The proposal to proceed with a National
Venous Screening Program in partnership with the AVA
was quickly approved by the AVF Executive Committee. A
formal AVF National Venous Screening Committee was
assembled shortly thereafter to complete the task, headed
by Robert McLafferty, MD, and including Marc Passman,
MD, W. Todd Bohannon, MD, Ruth Bush, MD, Tom
Rooke, MD, and Aamir Zakeria, MD.
From February to late October 2005, members from
the AVF Screening Committee, AVF Executive Commit-
tee, the AVA, and Administrare worked tirelessly to find
industry support, formulate a screening instrument, put
together a tool kit, create educational brochures, recruit
screening sites, and distribute materials to meet our original
November 7 “go-live” date. The tool kit includes a demo-
graphic section, a DVT risk assessment, a vascular labora-
tory assessment to determine reflux at the level of the
saphenous vein, femoral vein, and popliteal vein, a profes-
sional assessment of the legs to determine the CEAP clas-
sification of each limb, and a report card that the participant
will be able to take to his or her physician. The AVF and
AVA wish to thank Juzo for donating the funds to begin
this program.
November 7 to 11, 2005, marked the opening week for
National Screening for Venous Disease sponsored by the
AVF and the AVA. A total of 17 sites participated in the
screening, with 476 individuals screened. The formal re-
sults of this screening will be presented at the Eighteenth
Annual Meeting of the American Venous Forum and in a
subsequent publication by Robert McLafferty, MD, and his
screening committee. However, two highlights of the data
include the high frequency of participants at high or very
high risk for venous thromboembolism (if placed in a
situation in which such is likely, 77%), and the fact thatmore than 30% had varicose veins, and 20% were either
CEAP class 3 or greater. I would like to thank Dr McLaf-
ferty and his committee for their hard work on this initiative
and for the great collaboration with Dr. Flinn, Michele
Lentz, and the AVA.
Pacific vascular symposium. The next initiative is
the Pacific Vascular V Symposium and the venous cur-
riculum for the primary certificate in vascular surgery. The
AVF in conjunction with Past Presidents Robert Kistner,
MD, and Bo Eklof, MD, along with Fedor Lurie, MD, and
me, organized a very successful summit meeting “Pacific
Vascular V—Mapping the Future of Venous Disease” in
Hawaii, Jan 20 to 24, 2006. With sponsorship from 13
industrial partners and the Straub Foundation, the state of
the science and art of venous disease was presented and
then focused discussions led by a team of facilitators en-
sued. Over 60 faculty attended, divided between AVF
members and other non-AVF members from many differ-
ent disciplines, in addition to thought leaders from industry
and Dr Ahmed Hasan, Thrombosis and Hemostasis Pro-
gram, Division of Blood Diseases and Resources, National
Heart, Lung, and Blood Institute (NHLBI), National In-
stitutes of Health (NIH). These discussions led to a list of
more than 20 potential future projects in basic science
research and clinical studies to address areas of need for
knowledge in venous disease. The mission statement of this
conference was “To Promote Venous Health through In-
novative Research, Education, and Technology.” I learned
a new Hawaiian word, imua, which means to proceed
ahead in a positive fashion, that summed up the spirit of this
meeting. The organizers and writing captains (see below)
are developing a process to help facilitate the performance
of these projects to keep the spirit and enthusiasm alive
from this summit.
Results from Pacific Vascular V will include a supple-
ment to the Journal of Vascular Surgery on the current and
future status of venous disorders. This supplement is being
composed by a writing team led by Mark Mesissner, MD,
that includes Bo Eklof, MD, Greg Moneta, MD, Peter
Glovizcki, MD, and myself, with contributions from the
entire faculty of Pacific Vascular V. Additionally, in an effort
led by Secretary JoAnne Lohr, MD, guidelines for the
Venous Curriculum for the primary certificate in Vascular
Surgery have been complied from the authors of the Jour-
nal of Vascular Surgery supplement and have been submit-
ted to the Program Directors in Vascular Surgery. Finally,
this effort will complement the third edition of the Amer-
ican Venous Forum’s Handbook of Venous Disorders, edited
by Peter Gloviczki, which will be finished within the next
year.
Collaboration with other societies. This next initia-
tive involves a closer collaboration with other societies. The
AVF is working toward a closer collaborative relationship
with our colleagues in the American College of Phlebology
(ACP). Leaders of both organizations met in November
2004 in New York to discuss such a relationship. This year,
each organization will present a session at the other’s
annual meeting. We had a very successful presentation at
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San Francisco. Mark Mattos, MD, and I co-moderated a
session in which AVF members Rob McLafferty, MD,
Peter Neglan, MD, David Gillespie, MD, and Mark Meiss-
ner, MD, presented a stimulating program, “Endovascular
Techniques for the Treatment of Venous Disease.” The
topics included “Catheter Directed Management of Acute
DVT,” “Role of Stenting in Chronic Venous Disease of the
Lower Extremities,” “Venous Stenting for Central Venous
Obstruction,” and “Management of Complications of En-
dovenous Therapy.” At our Eighteenth Annual Meeting,
the ACP is presenting a session “Treatment of Venous
Disease: 2006.”
The AVF is also looking to expand its collaborations
with other societies. For example, this June the AVF will
partner with the European Venous Forum on a tripartite
meeting in London as part of the Seventh Meeting of the
European Venous Forum. Additional opportunities exist to
partner with other organizations and societies. The goal of
the AVF is to become the leading organization that reaches
out to those interested in venous disease throughout the
world.
Research. The next initiative is a new emphasis on
research in venous disease with the NIH. It has recognized
the importance of venous disease with recent requests
for applications entitled “Inflammation and Thrombosis”
released August 5, 2003, and “Critical Issues in Post-
phlebitic Syndrome” released December 29, 2004. The
importance that the NIH gives to venous disease and our
organization is highlighted by the fact that Dr Almed
Hasan from NIH joined and participated in Pacific VascularV, and Dr Pan Ganguly, the Director of the Thrombosis
and Hemostasis Program, Division of Blood Diseases and
Resources, NHLBI, NIH, has come as my Presidential
Guest Lecturer to the Eighteenth Annual Meeting of the
American Venous Forum. Finally, a Surgeon General’s
Workshop on Deep Vein Thrombosis will be held in May
2006. The AVF will be well represented at this workshop,
and we hope for a call to action on this most important
public health issue, venous thromboembolism.
FUTURE
I am very grateful for the spirit, enthusiasm, and energy
of members of the American Venous Forum. This is a very
important time in our organization’s history, and we have
the opportunity and obligation to be the leaders in all
aspects of venous diagnosis, treatment, and in both basic
and translational research. There is a new spirit of collabo-
ration and cooperation, and the American Venous Forum is
reaching out to those in other disciplines to come and join
our effort to improve the care of patients with venous
disorders. It is only through a better understanding of the
pathophysiology of venous disease and the generation of
strong experimental studies that improved treatments will
be developed. Indeed, for the American Venous Forum,
the future is now, and it has never looked brighter.
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